8-K
filed November 6, 2023, 6:59 PM ET
ticker MBOT
CIK 0000883975
other
confidence high
sentiment neutral
materiality 0.15
Microbot Medical shareholders elect directors, approve equity plan increase at 2023 annual meeting
Microbot Medical Inc.
- Scott Burell and Aileen Stockburger elected as Class II directors with 3.15M and 3.29M votes in favor, respectively.
- Amendment to 2020 Omnibus Performance Award Plan approved: share reserve increased by 600,000 to 2,020,652.
- Non-binding say-on-pay proposal approved with 2.20M votes in favor; board adopts one-year frequency for future votes.
- Ratification of Brightman Almagor Zohar & Co. (Deloitte affiliate) as independent auditor ratified with 6.10M votes in favor.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Microbot Medical Inc. shareholders approved Election of two nominees to serve as Class II Directors until the 2026 Annual Meeting at the 2023-11-02 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-11-02
Exact text from the filing
Proposal 1: Election of the two nominees listed below to serve as Class II Directors on the Board of Directors of the Company until the 2026 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: Name Number of Votes Cast in Favor Number of Votes Withheld Broker Non-Votes Scott Burell 3,151,413 656,060 2,629,648 Aileen Stockburger 3,287,071 520,402 2,629,648
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Microbot Medical Inc. shareholders approved Approval of amendment to 2020 Omnibus Performance Award Plan to increase authorized shares by 600,000 at the 2023-11-02 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-11-02
Exact text from the filing
Proposal 2: The approval of an amendment to the Company’s 2020 Omnibus Performance Award Plan, to increase the number of authorized shares of common stock reserved for issuance by 600,000, from 1,420,652 to 2,020,652: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained Broker Non-Votes 2,193,713 1,563,087 50,673 2,629,648
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Microbot Medical Inc. shareholders approved Ratification of Brightman Almagor Zohar & Co. as independent auditor for 2023 at the 2023-11-02 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-11-02
Exact text from the filing
Proposal 5: The ratification of Brightman Almagor Zohar & Co., a Member of Deloitte Touche Tohmatsu Limited, or its U.S. affiliate, as the Company’s independent registered public accounting firm for the year ending December 31, 2023: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained Broker Non-Votes 6,100,498 74,658 261,965 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Microbot Medical Inc. shareholders approved Advisory resolution supporting compensation of named executive officers at the 2023-11-02 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-11-02
Exact text from the filing
Proposal 3: The approval of a non-binding advisory resolution supporting the compensation of the Company’s named executive officers: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained Broker Non-Votes 2,197,751 1,547,396 62,326 2,629,648
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Microbot Medical Inc. shareholders approved Advisory resolution regarding frequency of future say-on-pay votes at the 2023-11-02 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-11-02
Exact text from the filing
Proposal 4: The approval of a non-binding advisory resolution regarding the frequency of future non-binding advisory votes related to named executive officer compensation: One Year Two Years Three Years Number of Votes Abstained Broker Non-Votes 2,201,561 86,486 1,383,749 135,677 2,629,648
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.